Showing results (61-70 of 154) with videos related to
Sort By:
Pageof 16
The International Journal of Biochemistry & Cell Biology|April 22, 2009
Study of the effects of a new pyrazolecarboxamide: changes in mitochondria and induction of apoptosisVincenzo Giansanti, Tania Camboni, Francesco Piscitelli, et al.Scientific Reports|July 11, 2020
Mutational analysis of the essential lipopolysaccharide-transport protein LptH of Pseudomonas aeruginosa to uncover critical oligomerization sitesRomina Scala, Adele Di Matteo, Antonio Coluccia, et al.Journal of Medicinal Chemistry|July 23, 2004
Imidazole analogues of fluoxetine, a novel class of anti-Candida agentsRomano Silvestri, Marino Artico, Giuseppe La Regina, et al.European Journal of Medicinal Chemistry|August 1, 2024
New potent EV-A71 antivirals targeting capsidHugo Roux, Franck Touret, Antonio Coluccia, et al.Cancer Biology & Therapy|January 21, 2016
Antiproliferative and proapoptotic effects of a pyrrole containing arylthioindole in human Jurkat leukemia cell line and multidrug-resistant Jurkat/A4 cellsAlex A Philchenkov, Michael P Zavelevich, Volodymyr P Tryndyak, et al.European Journal of Medicinal Chemistry|October 9, 2017
Heterocyclic pharmacochemistry of new rhinovirus antiviral agents: A combined computational and experimental studyLaurène Da Costa, Els Scheers, Antonio Coluccia, et al.Journal of Medicinal Chemistry|April 5, 2002
Synthesis, biological evaluation, and binding mode of novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles targeted at the HIV-1 reverse transcriptaseRomano Silvestri, Marino Artico, Gabriella De Martino, et al.Biology Direct|October 13, 2021
Targeting PDZ domains as potential treatment for viral infections, neurodegeneration and cancerCaterina Nardella, Lorenzo Visconti, Francesca Malagrinò, et al.European Journal of Medicinal Chemistry|July 22, 2022
Discovery of novel human lactate dehydrogenase inhibitors: Structure-based virtual screening studies and biological assessmentLaura Di Magno, Antonio Coluccia, Marianna Bufano, et al.Antimicrobial Agents and Chemotherapy|October 28, 2005
High potency of indolyl aryl sulfone nonnucleoside inhibitors towards drug-resistant human immunodeficiency virus type 1 reverse transcriptase mutants is due to selective targeting of different mechanistic forms of the enzymeReynel Cancio, Romano Silvestri, Rino Ragno, et al.Pageof 16